Trial Profile
A retrospective, observational study investigating efficacy of once monthly paliperidone palmitate in patients with newly diagnosed schizophrenia over a period of 12 months
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Oct 2016
Price :
$35
*
At a glance
- Drugs Paliperidone (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- 10 Oct 2016 New trial record